Skip to Main Content
Jeffrey Kahn, M.D.,  Ph.D.

Jeffrey Kahn, M.D., Ph.D.

Titles and Appointments

Chief, Division of Pediatric Infectious Disease

Professor & Division Chief

Endowed Title
Sarah M. and Charles E. Seay Chair in Pediatric Infectious Diseases
Schools
Medical School | Graduate School
Departments
Pediatrics | Microbiology
Graduate Programs
Molecular Microbiology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Jeffrey S. Kahn, M.D., Ph.D. received his Bachelor of Science degree in Microbiology and Immunology from McGill University. He received his M.D. and a Ph.D. in Microbiology and Immunology from the State University of New York Health Science Center at Brooklyn. Dr. Kahn completed his internship, residency and chief residency in Pediatrics at Yale University and the Children’s Hospital at Yale-New Haven Hospital. Dr. Kahn stayed at Yale University to complete training in Pediatric Infectious Diseases. Thereafter, he joined the faculty at Yale University in the Department of Pediatrics in the Division of Infectious Diseases. He joined the faculty of UT Southwestern Medical Center in 2009.

    Dr. Kahn’s research efforts have been focused human respiratory viruses, including respiratory syncytial virus (RSV) and new emerging human viruses. His laboratory was the first or among the first laboratories in the United States to describe the epidemiology and clinical manifestations of several newly identified viruses including human metapneumovirus, coronaviruses NL63 and HKU1, human bocavirus and polyomavirus WUV.  His laboratory has described the molecular epidemiology of RSV and has characterized the glycoprotein sequences, completed phylogenetic analyses and defined the biological properties (e.g. induction of cytokines and chemokines) and induced gene expression profiles (using RNA-SEQ) of many of these RSV strains in primary human cells. Dr. Kahn’s current research efforts are focuses on mapping RSV phenotypes in the viral genome.

    Dr. Kahn is the Director of the Pediatric Infectious Disease and the Pediatric Infectious Diseases Fellowship Program at UT Southwestern Medical Center and the Director of Infectious Diseases at Children’s Medical Center. Dr. Kahn is the Medical Director of Research at Children’s Medical Center.

  • Education
    Medical School
    SUNY Health Science Center at Brooklyn College of Medicine (1991)
    Residency
    Yale-New Haven Hospital (1994), Pediatrics
    Chief Resident
    Yale-New Haven Hospital (1995), Pediatrics
    Fellowship
    Yale University School of Medicine (1998), Pediatric Infectious Diseases
  • Research Interest
    • Cellular responses to RSV infection
    • Emerging pathogens
    • Recombinant negative stand RNA viruses
    • Respiratory syncytial virus
  • Publications
    Optical Nanobubble Amplification Enables Compartment- and Enzyme-Free Digital Attomolar Protein Absolute Quantification
    Zhang T, Gao Y, Liu Y, Zhang Y, Huynh HD, Chen J, Xie C, Ye H, Ge X, Kahn JS, Qin Z Nano Letters 2025 Nov 25 16443-16450
    Gastrointestinal Manifestations Are Associated with Severe COVID-19 in Children
    Akkoyun EB, Ashraf B, Hanners N, Kahn J, Most Z Healthcare (Switzerland) 2024 Jan 12
    Persistent symptoms and conditions among children and adolescents hospitalised with COVID-19 illness: A qualitative study
    Messiah SE, Francis J, Weerakoon S, Mathew MS, Shaikh S, Veeraswamy A, Lozano A, He W, Xie L, Polavarapu D, Ahmed N, Kahn J BMJ Open 2023 Sep 13
    Gold Nanourchins Improve Virus Targeting and Plasmonic Coupling for Virus Diagnosis on a Smartphone Platform
    Liu Y, Ye H, Bayram A, Zhang T, Cai Q, Xie C, Huynh HD, Peerzade SA, Kahn JS, Qin Z ACS Sensors 2022 Dec 7 3741-3752
    Digital plasmonic nanobubble detection for rapid and ultrasensitive virus diagnostics
    Liu Y, Ye H, Huynh HD, Xie C, Kang P, Kahn JS, Qin Z Nature communications 2022 Dec 13
    Comparison of Long-Term Complications of COVID-19 Illness among a Diverse Sample of Children by MIS-C Status
    Messiah SE, Xie L, Mathew MS, Shaikh S, Veeraswamy A, Rabi A, Francis J, Lozano A, Ronquillo C, Sanchez V, He W, Weerakoon SM, Srikanth N, Borel M, Kapera O, Kahn J International journal of environmental research and public health 2022 Oct 19
    Long-term physical, mental and social health effects of COVID-19 in the pediatric population: a scoping review
    Borel M, Xie L, Kapera O, Mihalcea A, Kahn J, Messiah SE World Journal of Pediatrics 2022 Mar 18 149-159
    mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses
    Huynh HD, Levitz R, Huang R, Kahn JS Scientific reports 2021 Dec 11
    Results of COVID-19 surveillance in a large United States pediatric healthcare system over one year
    Messiah SE, Xie L, Mathew MS, Delclos GL, Kohl HW, Kahn JS Children 2021 Sep 8
    Cardiac Modeling for Multisystem Inflammatory Syndrome in Children (MIS-C, PIMS-TS)
    Waugh R, Hussein MA, Weller J, Sharma K, Greil G, Kahn J, Hussain T, Chabiniok R 2021 435-446
  • Books

    Featured 

  • Honors & Awards
    • Best Pediatric Specialists/Doctors in Dallas
      D Magazine (2014-2018)
    • Pediatric Chair’s Award, Yale University School of Medicine
      (2005)
    • Mae Gailani Junior Faculty Award, Yale University School of Medicine
      (2002)
  • Professional Associations/Affiliations
    • American Academy of Pediatrics
    • American Society of Microbiology (2001)
    • American Society of Virology (2002)
    • Infectious Diseases Society of America (2010)
    • Society of Pediatric Research (2001)